GOAL OF WORK: The aim of the study was to investigate if the International Classification of Functioning, Disability and Health (ICF) model with clinical data from patients with breast-cancer-related lymphedema can predict their health-related quality of life (HRQL). MATERIALS AND METHODS: Sixty-one patients with breast-cancer-related lymphedema were recruited. Data were collected from records, including age, type(s) of surgery, number of dissected lymph nodes and history of radiotherapy and/or chemotherapy, duration of lymphedema, and duration between surgery and enrollment. Excessive arm volume, average arm symptom, function of upper extremity (U/E), and HRQL were assessed four times during and after patients' treatment of lymphedema. RESULTS: The ICF model accounted for 20.5% to 55.6% variance in each domain of HRQL. Activity and participation reflected by U/E function were the most important factor, significantly predicting every domain of HRQL. Among measured impairments, average arm symptom was found to be most correlated with U/E function (r = 0.590, P < 0.05). CONCLUSION: The ICF model consisting of clinical measures for patients with breast-cancer-related lymphedema can predict their HRQL. Activity and participation were the most important component. Arm symptoms rather than arm volume significantly correlated with U/E function. This might suggest that reducing arm symptoms is relatively more important while treating patients with breast-cancer-related lymphedema.
GOAL OF WORK: The aim of the study was to investigate if the International Classification of Functioning, Disability and Health (ICF) model with clinical data from patients with breast-cancer-related lymphedema can predict their health-related quality of life (HRQL). MATERIALS AND METHODS: Sixty-one patients with breast-cancer-related lymphedema were recruited. Data were collected from records, including age, type(s) of surgery, number of dissected lymph nodes and history of radiotherapy and/or chemotherapy, duration of lymphedema, and duration between surgery and enrollment. Excessive arm volume, average arm symptom, function of upper extremity (U/E), and HRQL were assessed four times during and after patients' treatment of lymphedema. RESULTS: The ICF model accounted for 20.5% to 55.6% variance in each domain of HRQL. Activity and participation reflected by U/E function were the most important factor, significantly predicting every domain of HRQL. Among measured impairments, average arm symptom was found to be most correlated with U/E function (r = 0.590, P < 0.05). CONCLUSION: The ICF model consisting of clinical measures for patients with breast-cancer-related lymphedema can predict their HRQL. Activity and participation were the most important component. Arm symptoms rather than arm volume significantly correlated with U/E function. This might suggest that reducing arm symptoms is relatively more important while treating patients with breast-cancer-related lymphedema.
Authors: Johan S Rietman; Pieter U Dijkstra; Rolanda Debreczeni; Jan H B Geertzen; Douglas P H Robinson; Jaap De Vries Journal: Disabil Rehabil Date: 2004-01-21 Impact factor: 3.033
Authors: Carmit Mcmullen; Liyan Liu; Joanna E Bulkley; Mark C Hornbrook; Christopher Wendel; Marcia Grant; Andrea Altschuler; Larissa Kf Temple; Robert S Krouse; Lisa Herrinton Journal: Perm J Date: 2017
Authors: Jean O'Toole; Lauren S Jammallo; Melissa N Skolny; Cynthia L Miller; Krista Elliott; Michelle C Specht; Alphonse G Taghian Journal: Crit Rev Oncol Hematol Date: 2013-06-16 Impact factor: 6.312